Inventor
ZOU DAOZHONG
US21 patents
⚠️ This page may combine multiple inventors who share the name “ZOU DAOZHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
5 patentsUS9814713B2Nov 14, 2017
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
SIGNAL PHARM LLC14 citations92
US9365524B2Jun 14, 2016
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
SIGNAL PHARM LLC22 citations92
US9796685B2Oct 24, 2017
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methylcyclohexylamino)-pyrimidine-5-carboxamide
SIGNAL PHARM LLC14 citations89
US10590089B2Mar 17, 2020
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
SIGNAL PHARM LLC1 citations70
US10131639B2Nov 20, 2018
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrimidine-5-carboxamide
SIGNAL PHARM LLC4 citations70
CELGENE CAR LLC
4 patentsUS10882867B2Jan 5, 2021
Forms and compositions of a MK2 inhibitor
CELGENE CAR LLC8 citations82
US11629153B2Apr 18, 2023
Forms and compositions of a MK2 inhibitor
CELGENE CAR LLC1 citations60
US10005760B2Jun 26, 2018
Forms and compositions of an ERK inhibitor
CELGENE CAR LLC1 citations60
US10202364B2Feb 12, 2019
Forms and compositions of an ERK inhibitor
CELGENE CAR LLC0 citations49
NOVARTIS AG
4 patentsUS11434200B2Sep 6, 2022
Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof
NOVARTIS AG2 citations72
US12049446B2Jul 30, 2024
Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof
NOVARTIS AG0 citations62
US11958805B2Apr 16, 2024
Solid forms comprising an oxime ether compound, compositions and methods of use thereof
NOVARTIS AG0 citations62
US11629124B2Apr 18, 2023
Solid forms comprising an oxime ether compound, compositions and methods of use thereof
NOVARTIS AG1 citations62
CELGENE CORP
4 patentsUS11013723B1May 25, 2021
Solid forms of a thiazolidinone compound, compositions and methods of use thereof
CELGENE CORP2 citations72
US11014897B1May 25, 2021
Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
CELGENE CORP0 citations62
US11186556B1Nov 30, 2021
Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
CELGENE CORP0 citations51
US10064863B2Sep 4, 2018
Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione
CELGENE CORP0 citations43